Compare GTBP & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTBP | HUIZ |
|---|---|---|
| Founded | 1965 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 16.8M |
| IPO Year | 2016 | 2019 |
| Metric | GTBP | HUIZ |
|---|---|---|
| Price | $0.38 | $1.22 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.30 |
| AVG Volume (30 Days) | ★ 1.3M | 13.4K |
| Earning Date | 05-15-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | N/A | $6.64 |
| P/E Ratio | ★ N/A | $7.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $1.04 |
| 52 Week High | $2.29 | $4.16 |
| Indicator | GTBP | HUIZ |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 48.85 |
| Support Level | $0.29 | $1.19 |
| Resistance Level | $0.46 | $1.55 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 27.16 | 64.52 |
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.